Vyant Bio, Inc.

VYNT · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$23-$41-$9-$7
Dep. & Amort.$1$1$1$1
Deferred Tax$0-$0-$0$0
Stock-Based Comp.$1$1$0$0
Change in WC$1-$3$1$18
Other Non-Cash$6$25$0-$21
Operating Cash Flow-$14-$17-$6-$9
Investing Activities
PP&E Inv.-$1-$1-$0-$0
Net Acquisitions$0$30$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4-$0$0$9
Investing Cash Flow$3$30-$0$9
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$0$0$1$5
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$7$6$3
Financing Cash Flow-$0$7$6$3
Forex Effect$0$0-$0-$0
Net Chg. in Cash-$11$20$0$4
Supplemental Information
Beg. Cash$21$1$0$1
End Cash$10$21$1$4
Free Cash Flow-$14-$18-$6-$9